Linda Higgins
Director/Board Member at GALAPAGOS NV
Linda Higgins active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GALAPAGOS NV | Director/Board Member | 2019-10-21 | - |
| Independent Dir/Board Member | 2019-10-21 | 2023-04-24 | |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2009-12-31 | - |
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 2021-08-09 | - |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Director/Board Member | - | - |
Career history of Linda Higgins
Former positions of Linda Higgins
| Companies | Position | Start | End |
|---|---|---|---|
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | - | - |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Director/Board Member | 2010-12-28 | - |
| Chief Operating Officer | 2009-09-15 | 2010-12-28 | |
| Chief Tech/Sci/R&D Officer | 2006-12-31 | 2009-09-15 | |
| President | 2010-05-10 | 2010-12-28 |
Training of Linda Higgins
| Kenyon College | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Statistics
International
| United States | 8 |
| Belgium | 2 |
Operational
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| GALAPAGOS NV | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Linda Higgins
- Experience
